100 Scientific Studies:  Diabetes And Blindness

Search Results on September 7, 2000

 

Results for your query:
Words in title only: diabetes And blindness
Published in 1966 through 1999
Only select references with abstracts available
Show references published in English only
Show references pertaining to humans

Documents: 1 to 11 of 11

1

Top Of Menu

Lee BL, et al; Chiasmal infarction and sudden blindness caused by mucormycosis in AIDS and diabetes mellitus. (Am J Ophthalmol, 1996 Dec, Abstract available) [MEDLINE]

2 Blindness caused by diabetes--Massachusetts, 1987-1994. (MMWR Morb Mortal Wkly Rep, 1996 Nov, Abstract available) [MEDLINE]
3 Bäcklund LB, et al; New blindness in diabetes reduced by more than one-third in Stockholm County. (Diabet Med, 1997 Sep, Abstract available) [MEDLINE]
4 Rhatigan MC, et al; Blindness in patients with diabetes who have been screened for eye disease. (Eye, 1999 Apr, Abstract available) [MEDLINE]
5 Herman WH, et al; An approach to the prevention of blindness in diabetes. (Diabetes Care, 1983 Nov, Abstract available) [MEDLINE]
6 Sorensen PN; Transitory blindness during ethanol and phenethylbiguanide induced lactic acidosis in a subject with diabetes mellitus. A case report. (Acta Ophthalmol (Copenh), 1977 Apr, Abstract available) [MEDLINE]
7 Plechaty G, et al; Elimination of preventable blindness from diabetes by the year 2000. (Hawaii Med J, 1992 Jul, Abstract available) [MEDLINE]
8 Moskalets E, et al; Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. (J Diabetes Complications, 1994 Jan, Abstract available) [MEDLINE]
9 Kivelä T, et al; Diabetes insipidus and blindness caused by a suprasellar tumor: Pieter Pauw's observations from the 16th century [see comments] (JAMA, 1998 Jan, Abstract available) [MEDLINE]
10

Trautner C, et al; Incidence of blindness in relation to diabetes. A population-based study. (Diabetes Care, 1997 Jul, Abstract available) [MEDLINE]

11 Icks A, et al; Blindness due to diabetes: population-based age- and sex-specific incidence rates. (Diabet Med, 1997 Jul, Abstract available) [MEDLINE]


Click here for more information!  

Information on HealthGate.com is not a substitute for professional medical care or advice but should be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.

We subscribe to the HONcode principles
of the Health On the Net Foundation

Send comments to support@healthgate.com
Copyright © 2000 HealthGate® Data Corp. All rights reserved.


       

Record 1 from database: MEDLINE
Return To Top

Title
Chiasmal infarction and sudden blindness caused by mucormycosis in AIDS and diabetes mellitus.
Author
Lee BL; Holland GN; Glasgow BJ
Address
UCLA Ocular Inflammatory Disease Center, USA.
Source
Am J Ophthalmol, 1996 Dec, 122:6, 895-6
Abstract
PURPOSE: To report rapidly progressive rhino-orbitocerebral mucormycosis in a 47-year-old woman with both diabetes mellitus and the acquired immunodeficiency syndrome (AIDS). METHOD: Case report including postmortem examination of the eyes, orbit, and brain of a patient with rhino-orbitocerebral mucormycosis, diabetes mellitus, and AIDS. RESULTS: Invasion by hyphae of the Rhizopus species produced an occlusive vasculitis and massive infarction of the optic chiasm. Fungal organisms were discovered in multiple granulomata of the optic nerve. CONCLUSION: Infarction at the optic chiasm probably caused sudden blindness in this patient.
Language of Publication
English
Unique Identifier
97115249

Return To Top


MeSH Heading (Major)
Acquired Immunodeficiency Syndrome|*CO; Blindness|*ET/PA; Cerebral Infarction|*MI/PA; Diabetes Mellitus|*CO; Eye Infections, Fungal|*ET/PA; Mucormycosis|*CO; Optic Chiasm|*BS/MI
MeSH Heading
Case Report; Female; Human; Middle Age; Optic Nerve|MI; Orbital Diseases|MI/PA; Paranasal Sinus Diseases|MI/PA; Rhizopus|IP

Publication Type
JOURNAL ARTICLE
ISSN
0002-9394
Country of Publication
UNITED STATES

Record 2 from database: MEDLINE
Return To Top

Title
Blindness caused by diabetes--Massachusetts, 1987-1994.
Address
 
Source
MMWR Morb Mortal Wkly Rep, 1996 Nov, 45:43, 937-41
Abstract
Diabetes, the leading cause of new blindness among U.S. adults aged 20-74 years, accounts for approximately 8% of cases of legal blindness and 12% of all new cases of blindness in the United States each year. One of the national health objectives for the year 2000 is to decrease by 50% the incidence of blindness caused by diabetes (objective 17.10). However, surveillance for blindness among persons with diabetes has not been conducted nationally, and national prevalence estimates of blindness caused by diabetes have been based on state data from the register of the Massachusetts Commission for the Blind (MCB). To characterize recent trends, data on legal blindness caused by diabetes among adults with diabetes in Massachusetts were examined for 1987-1994. This report summarizes the results of that analysis, which indicate that in Massachusetts, the overall incidence and prevalence of legal blindness caused by diabetes did not decrease, despite the availability of methods to prevent vision loss.
Language of Publication
English
Unique Identifier
97056095

Return To Top


MeSH Heading (Major)
Blindness|EP/*ET; Diabetes Mellitus|*CO
MeSH Heading
Adult; Aged; Female; Human; Incidence; Male; Massachusetts|EP; Middle Age; Prevalence

Publication Type
JOURNAL ARTICLE
ISSN
0149-2195
Country of Publication
UNITED STATES

Record 3 from database: MEDLINE
Return To Top

Title
New blindness in diabetes reduced by more than one-third in Stockholm County.
Author
Bäcklund LB; Algvere PV; Rosenqvist U
Address
Department of Ophthalmology, Karolinska Institutet, St Erik's Eye Hospital, Stockholm, Sweden.
Source
Diabet Med, 1997 Sep, 14:9, 732-40
Abstract
To monitor changes over time in the incidence of blindness among people with diabetes, referrals (mentioning diabetes) to all vision rehabilitation centres in Stockholm County (1995 population 1 725 756) during 1981-1995 were registered. A mass mailing to people with diabetes in 1989 urged them to have their eyes examined. Mobile fundus photography teams initiated early diagnosis of diabetic retinopathy in primary health care in 1990. Referrals with diabetes and blindness, defined (WHO, ICD 10) as best-corrected visual acuity (VA) of the better eye less than 3/60 (0.05), occurred for 172 persons (7.6% of those referred with diabetes). During 1981-1985, 93 were referred (95% confidence interval 75 to 114); 1986-1990, 51 (38 to 67); 1991-1995, 28 (19 to 41). Five-year average annual incidence rate of referrals with blindness was reduced by 47% from 1.2 to 0.63 to 0.33 per 100,000 population. Mean yearly reduction during 1981-1995 was 11% (8 to 15%), 11.5% (8 to 15%) if blindness was defined as in the UK (VA 3/60 or less), and 7% (4 to 9%) for legal blindness (VA 6/60 or less); test for trend p < 0.001 (Poisson regression analysis). This is the first report of reduction in a geographical region of a proxy measure for new blindness in diabetes by one-third or more, attaining one of the main targets of the St Vincent Declaration.
Language of Publication
English
Unique Identifier
97445337

Return To Top


MeSH Heading (Major)
Blindness|*EP/PC; Diabetes Mellitus|*CO; Diabetic Retinopathy|*EP/PC
MeSH Heading
Adult; Age Distribution; Aged; Aged, 80 and over; Comparative Study; Female; Human; Incidence; Male; Middle Age; Sex Distribution; Support, Non-U.S. Gov't; Sweden|EP; Time Factors; Vision, Low|RH; Visual Acuity

Publication Type
JOURNAL ARTICLE
ISSN
0742-3071
Country of Publication
ENGLAND

Record 4 from database: MEDLINE
Return To Top

Title
Blindness in patients with diabetes who have been screened for eye disease.
Author
Rhatigan MC; Leese GP; Ellis J; Ellingford A; Morris AD; Newton RW; Roxburgh ST
Address
Department of Ophthalmology, Ninewells Hospital and Medical School, Dundee, UK.
Source
Eye, 1999 Apr, 13 ( Pt 2):, 166-9
Abstract
PURPOSE: Detection of diabetic retinopathy by screening is a major public health concern. Fundus photography has been shown to be a useful screening tool for the detection of diabetic retinopathy. In this paper the authors assess the incidence of blind and partially sighted registration due to diabetic eye disease in patients screened by a mobile fundus photography unit and identify the factors that contributed to loss of vision in the registered group. METHODS: A retrospective review of blind and partially sighted registrations between 1990 and 1995 was performed in a diabetic population screened by a mobile fundus photography unit in a region with a population of 390,000. The incidence of blind and partially sighted registration in the screened diabetic population was calculated. In the registered group, cause of visual loss, accuracy of photograph reporting, delay in laser treatment, adequacy of laser treatment and non-attendance rates at ophthalmic clinics were assessed. RESULTS: Of the 5390 patients screened by the mobile unit over 6 years, 68 (210 per 10(5) patient-years) were registered blind or partially sighted, but in only 17 patients (53 per 10(5) patient-years) was this as a result of diabetes. The factors contributing to loss of vision were found to be failure of laser treatment, rapidly progressive disease and poor patient attendance. CONCLUSIONS: As the majority of visual impairment in patients with diabetes is not due to diabetic retinopathy, this has important implications for screening programmes and may make the St Vincent Declaration targets difficult to achieve. The rate of new blind and partially sighted registration due to diabetes in the screened population was low at 53 per 10(5) patient-years (95% confidence interval, 29-76).
Language of Publication
English
Unique Identifier
99378869

Return To Top


MeSH Heading (Major)
Blindness|DI/EP/*ET; Diabetic Retinopathy|*CO/SU; Vision Screening|*
MeSH Heading
Adult; Aged; Aged, 80 and over; Female; Fundus Oculi; Human; Incidence; Laser Coagulation; Male; Middle Age; Mobile Health Units; Patient Acceptance of Health Care; Retrospective Studies; Scotland|EP; Treatment Failure

Publication Type
JOURNAL ARTICLE
ISSN
0950-222X
Country of Publication
ENGLAND

Record 5 from database: MEDLINE
Return To Top

Title
An approach to the prevention of blindness in diabetes.
Author
Herman WH; Teutsch SM; Sepe SJ; Sinnock P; Klein R
Address
 
Source
Diabetes Care, 1983 Nov, 6:6, 608-13
Abstract
Diabetic eye disease is the leading cause of new cases of legal blindness in American adults under the age of 65 yr. Diabetic persons are at risk for visual loss due to diabetic retinopathy, glaucoma, and cataracts. Better understanding of the natural histories of these complications and recent advances in treatment have provided a rationale for developing an approach to prevent visual loss. This approach requires that diabetic patients who are at high risk for visual loss, and not under the care of ophthalmologists, be systematically screened, referred, and treated.
Language of Publication
English
Unique Identifier
84083937

Return To Top


MeSH Heading (Major)
Blindness|DI/ET/*PC; Diabetes Mellitus|*CO/ME/PP/TH
MeSH Heading
Adult; Animal; Blood Pressure; Cataract|ET/PC; Cataract Extraction; Diabetes Mellitus, Experimental|TH; Diabetic Retinopathy|PC/SU; Dogs; Female; Glaucoma|ET/PC/TH; Human; Lasers|TU; Macula Lutea|SU; Pregnancy; Risk; Vitrectomy

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0149-5992
Country of Publication
UNITED STATES

Record 6 from database: MEDLINE
Return To Top

Title
Transitory blindness during ethanol and phenethylbiguanide induced lactic acidosis in a subject with diabetes mellitus. A case report.
Author
Sorensen PN
Address
 
Source
Acta Ophthalmol (Copenh), 1977 Apr, 55:2, 177-82
Abstract
Transitory blindness is described in a diabetic patient with typical ethanol- and phenethylbiguanide induced lactic acidosis. The blindness developed in the course of 8 hours, but the vision returned during treatment with iv bicarbonate, insulin and glucose. The condition is discussed in relation to a presumed inhibition of the oxidative metabolism in the retina.
Language of Publication
English
Unique Identifier
77178472

Return To Top


MeSH Heading (Major)
Alcoholic Intoxication|*CO; Blindness|*CI; Diabetic Ketoacidosis|BL/*CI/CO; Diabetic Retinopathy|*CI; Phenformin|*AE
MeSH Heading
Case Report; Female; Human; Lactates|BL; Middle Age

Publication Type
JOURNAL ARTICLE
ISSN
0001-639X
Country of Publication
DENMARK

Record 7 from database: MEDLINE
Return To Top

Title
Elimination of preventable blindness from diabetes by the year 2000.
Author
Plechaty G; Smith RE; Patz A
Address
 
Source
Hawaii Med J, 1992 Jul, 51:7, 186, 196
Abstract
"Diabetes 2000" will parallel a major diabetic retinopathy public information campaign recently announced by the National Eye Institute. The NEI's National Eye Health Education Program (NEHEP), which targets both diabetic retinopathy and glaucoma, is fashioned along the lines of earlier federal initiatives against smoking and high blood pressure. By continuously updating our medical knowledge and skills related to this multisystem disorder, and by forging partnerships between physicians in the effective and efficient management of diabetic patients, we have a unique and important opportunity--we can reduce preventable blindness from diabetes by the year 2000.
Language of Publication
English
Unique Identifier
92387913

Return To Top


MeSH Heading (Major)
Blindness|*PC; Diabetic Retinopathy|*PC
MeSH Heading
Forecasting; Hawaii; Human

Publication Type
JOURNAL ARTICLE
ISSN
0017-8594
Country of Publication
UNITED STATES

Record 8 from database: MEDLINE
Return To Top

Title
Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus.
Author
Moskalets E; Galstyan G; Starostina E; Antsiferov M; Chantelau E
Address
Diabetes Care and Education Unit, National Center for Endocrinology, Moscow, Russia.
Source
J Diabetes Complications, 1994 Jan, 8:1, 45-50
Abstract
Intensive glycemic control (IGC) in previously hyperglycemic insulin-dependent diabetes mellitus (IDDM) patients is associated with a decreased long-term risk of progression of diabetic retinopathy (DR); up to 12 months after institution of IGC, however, the risk of progression of DR transiently increases. In an observational study, a cohort of 122 patients with IDDM was followed prospectively for changes in glycosylated hemoglobin (HbA1, normal < 8%) and in DR 0-12 months after institution of IGC. In six of these patients (women, mean age 24 years, duration of diabetes 14.3 years, with incipient nephropathy and retinopathy) a total of seven eyes went blind after 6-12 months of IGC, despite laser coagulation treatment. From the whole sample, a control groups of eight patients (six women) was set up, matched for age, duration of IDDM, degree of retinopathy, visual acuity, blood pressure, and microalbuminuria, with preserved vision after 12 months of IGC. In the case patients, the mean (95% confidence interval) initial HbA1 was 14.9% (13.8%-16.1%), versus 13.4% (12.4%-14.4%) in the control patients (p < 0.05). The mean HbA1 decrements after 4 months of IGC, were 3.0% (1.9%-4.1%) in the cases, and 2.1% (1.2%-3.0%) in the controls (NS); and after 12 months, the respective decrements were 4.9% (2.4%-7.4%) in the cases versus 2.0% (0.5%-3.5%) in the controls (p = 0.04). In conclusion, IGC with a decrement of > 2% per year is associated with a high risk of progression of antecedent diabetic retinopathy to blindness in IDDM patients with an extremely high initial HbA1.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
94220761

Return To Top


MeSH Heading (Major)
Blindness|*EP; Blood Glucose|*ME; Diabetes Mellitus, Insulin-Dependent|BL/*PP/RH; Diabetic Retinopathy|*PP; Patient Education|*
MeSH Heading
Adolescence; Adult; Female; Follow-Up Studies; Human; Male; Risk Factors; Support, Non-U.S. Gov't; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
1056-8727
Country of Publication
UNITED STATES

Record 9 from database: MEDLINE
Return To Top

Title
Diabetes insipidus and blindness caused by a suprasellar tumor: Pieter Pauw's observations from the 16th century [see comments]
Author
Kivelä T; Pelkonen R; Oja M; Heiskanen O
Address
Department of Ophthalmology, Helsinki University Central Hospital, Finland. tekivela@cc.helsinki.fi
Source
JAMA, 1998 Jan, 279:1, 48-50
Abstract
Tumors in the suprasellar region may cause both visual and endocrinologic symptoms. This association, well known to modern physicians, was established during the 19th century. However, we have identified a 16th-century autopsy report, written by the Dutch professor of anatomy Pieter Pauw (1564-1617), which describes an 18-year-old girl who developed marked polyuria and subsequently became totally blind from a cystic tumor compressing the optic chiasm. Based on prevailing theories on the nature of diabetes, Pauw attributed the disease to the kidneys. Undoubtedly, however, his lucid report is the earliest known account of diabetes insipidus caused by an arachnoid cyst, the Rathke cleft cyst, or craniopharyngioma in the region of the pouch of Rathke. The description also gives insights into the role of anatomic dissections in late 16th-century northern Europe.
Language of Publication
English
Unique Identifier
98084659

Return To Top


MeSH Heading (Major)
Craniopharyngioma|CO/*HI; Diabetes Insipidus|ET/*HI
MeSH Heading
Anatomy|HI; Autopsy|HI; Blindness|ET/HI; Female; History of Medicine, 16th Cent.; Human; Netherlands; Portraits

Publication Type
BIOGRAPHY; HISTORICAL ARTICLE; JOURNAL ARTICLE
ISSN
0098-7484
Country of Publication
UNITED STATES

Record 10 from database: MEDLINE
Return To Top

Title
Incidence of blindness in relation to diabetes. A population-based study.
Author
Trautner C; Icks A; Haastert B; Plum F; Berger M
Address
Department of Biometrics and Epidemiology, Diabetes Research Institute, Heinrich Heine University, DÂusseldorf, Germany. trau@dfi.uni-duesseldorf.de
Source
Diabetes Care, 1997 Jul, 20:7, 1147-53
Abstract
OBJECTIVE: A reduction of diabetes-related blindness was declared a primary objective for Europe (St. Vincent Declaration). We collected data about incidence rates of blindness in the diabetic population compared with the nondiabetic population. Up to now, such data are scarce-even worldwide. RESEARCH DESIGN AND METHODS: A complete list of newly registered blindness allowance recipients was drawn up in the district of Württemberg-Hohenzollern, Germany, between 1990 and 1993. From these data, we estimated age-specific and standardized incidence rates of blindness in the entire, the diabetic, and the nondiabetic population, as well as relative and attributable risks due to diabetes. RESULTS: There were 2,714 people meeting the inclusion criteria; 1,823 (67.2%) were female and 781 (28.8%) had diabetes. In 318 subjects, diabetes was likely to be the only cause of blindness; in 192 subjects, it was one of several contributory causes. Age of women was 73.9 +/- 19.4 years (mean +/- SD) and of men 63.3 +/- 25.5 years. Results standardized to the (West) German population are as follows: incidence rates (per 100,000 person-years): total population: 13.5; diabetic population: 60.6; nondiabetic population: 11.6; relative risk: 5.2; attributable risk among exposed: 0.81; and population attributable risk: 0.14. The relative risks decreased considerably with increasing age. When the study is repeated to monitor the St. Vincent targets, a reduction in the incidence rate of blindness in the diabetic population by 17% will be detected with 95% power. CONCLUSIONS: Great relative and attributable risks, especially in younger age-groups, indicate the need for increased attention to preventive measures for microvascular complications.
Language of Publication
English
Unique Identifier
97347089

Return To Top


MeSH Heading (Major)
Blindness|*EP/ET; Diabetes Mellitus|*CO
MeSH Heading
Adolescence; Adult; Age Factors; Aged; Aged, 80 and over; Child; Comparative Study; Female; Germany|EP; Human; Incidence; Male; Middle Age; Risk Factors; Sex Characteristics; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0149-5992
Country of Publication
UNITED STATES

Record 11 from database: MEDLINE
Return To Top

Title
Blindness due to diabetes: population-based age- and sex-specific incidence rates.
Author
Icks A; Trautner C; Haastert B; Berger M; Giani G
Address
Department of Biometrics and Epidemiology, Diabetes Research Institute at DÂusseldorf University, Germany.
Source
Diabet Med, 1997 Jul, 14:7, 571-5
Abstract
Reducing the incidence of diabetic retinopathy and blindness was declared one of the main objectives in St Vincent. To date, hardly any valid data are available on the age- and sex-specific incidence of diabetes-related blindness. They are necessary, however, to evaluate intervention activities. Therefore, we used a population-based registry of blindness to calculate incidence of blindness due to diabetes. In one German district (Rhineland) we obtained complete lists of cases of blindness newly registered in 1990 and 1991 and coded as blind due to diabetes (n = 589). We estimated age-specific incidence rates in the entire as well as in the diabetic population. Incidence rates of blindness due to diabetes (100,000(-1) * year(-1)), standardized to the West-German population, were 3.2 (CI 95%: 2.9;3.4) in the entire population and 60.5 (CI 95%: 45.7;75.4) in the diabetic population. Incidence rates in the diabetic population showed a peak between 20 and 40 years of age, probably due to complications of Type 1 diabetes. Incidence was higher in diabetic women than in diabetic men (p < 0.05 at ages > or =40 years). Repeating the study will detect a decrease in the incidence of blindness due to diabetes by one-third with over 99% power.
Language of Publication
English
Unique Identifier
97366565

Return To Top


MeSH Heading (Major)
Blindness|*EP/*ET; Diabetic Retinopathy|*CO
MeSH Heading
Adolescence; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Germany|EP; Human; Incidence; Infant; Infant, Newborn; Male; Middle Age; Reference Standards; Registries|SN/ST; Sex Factors; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0742-3071
Country of Publication
ENGLAND

Information on HealthGate.com is not a substitute for professional medical care or advice but should be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.

We subscribe to the HONcode principles
of the Health On the Net Foundation

Send comments to support@healthgate.com
Copyright © 2000 HealthGate® Data Corp. All rights reserved.

Return To Top

Home Page -- Karl Loren Web Site Navigation Bar
Karl Loren Diet Cancer & Biopsies Oral Chelation High Cholesterol Risk Factor
Karl Loren's Personal
Diet Diary
Ultrasound Technology Karl Loren Personal Plaque Isn't Where They Say It Is
Aajonus Vonderplanitz Arthritis Karl's Adventure
 With The IRS
Bones Are Alive
Diabetes Table Of Contents Jean Ross Witch Doctors & Ethnobotany
Sugar Shopping Cart Order Karl Loren's Book
On Heart Disease
AIDS
Raw Milk Search  This Web Write To Karl Loren Right To Die
Why You Should Drink More Water Transfer Factor & The Immune System What Is A Free Radical? Methyl Sulfonyl Methane
Taheebo Tea Germanium Corruption In The American Heart Association James Coburn's Use Of MSM To Handle Arthritis
Floaters Rather Than Sinkers Toxic Metals Heart Disease Jimmy Keller -- Forbidden Medicine
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Karl Loren's Catalog Store Central Page For All 12 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

 


SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

[FrontPage Save Results Component]

Please provide the following contact information:

First name required
Last name required
Middle initial
Information
Request
 

 

Title
Organization
Work Phone
Home Phone
FAX
E-mail required
URL
Address 1 requested
Address 2
City requested
State/Province requested
Zip Code requested
Countryrequested

How Did You Find This Web Site?

Select one

 

What do you think of this site or ... ?  I promise to answer your comments, personally.



Click here to add the Wednesday Letter as a Channel on your desktop.   If your browser is so-equipped, you will be guided through a series of simple questions (about subscription information).  Depending on your choices you can show the Vibrant Life Wednesday Letter as one of your "active channels" which will automatically download the new Wednesday Letter every month.  In this way you can have the Wednesday Letter delivered to your desktop during the night (or your schedule) for immediate viewing in your browser.  You can turn on or off this channel, at will, and delete the channel from your desktop at any time.  With this feature operating you can click on the Wednesday Letter channel at any time to read the most recent copy of this electronic letter.


You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.

[FrontPage Save Results Component]

Please provide the following contact information:

First name required
Last name required
Middle initial
Information
Request
 

 

Title
Organization
Work Phone
Home Phone
FAX
E-mail required
URL
Address 1 requested
Address 2
City requested
State/Province requested
Zip Code requested
Countryrequested

How Did You Find This Web Site?

Select one

 

What do you think of this site or ... ?  I promise to answer your comments, personally.



Click here to add the Wednesday Letter as a Channel on your desktop.   If your browser is so-equipped, you will be guided through a series of simple questions (about subscription information).  Depending on your choices you can show the Vibrant Life Wednesday Letter as one of your "active channels" which will automatically download the new Wednesday Letter every month.  In this way you can have the Wednesday Letter delivered to your desktop during the night (or your schedule) for immediate viewing in your browser.  You can turn on or off this channel, at will, and delete the channel from your desktop at any time.  With this feature operating you can click on the Wednesday Letter channel at any time to read the most recent copy of this electronic letter.


You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.

[FrontPage Save Results Component]

Please provide the following contact information:

First name required
Last name required
Middle initial
Information
Request
 

 

Title
Organization
Work Phone
Home Phone
FAX
E-mail required
URL
Address 1 requested
Address 2
City requested
State/Province requested
Zip Code requested
Countryrequested

How Did You Find This Web Site?

Select one

 

What do you think of this site or ... ?  I promise to answer your comments, personally.



Click here to add the Wednesday Letter as a Channel on your desktop.   If your browser is so-equipped, you will be guided through a series of simple questions (about subscription information).  Depending on your choices you can show the Vibrant Life Wednesday Letter as one of your "active channels" which will automatically download the new Wednesday Letter every month.  In this way you can have the Wednesday Letter delivered to your desktop during the night (or your schedule) for immediate viewing in your browser.  You can turn on or off this channel, at will, and delete the channel from your desktop at any time.  With this feature operating you can click on the Wednesday Letter channel at any time to read the most recent copy of this electronic letter.


You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.

[FrontPage Save Results Component]

Please provide the following contact information:

First name required
Last name required
Middle initial
Information
Request
 

 

Title
Organization
Work Phone
Home Phone
FAX
E-mail required
URL
Address 1 requested
Address 2
City requested
State/Province requested
Zip Code requested
Countryrequested

How Did You Find This Web Site?

Select one

 

What do you think of this site or ... ?  I promise to answer your comments, personally.



Click here to add the Wednesday Letter as a Channel on your desktop.   If your browser is so-equipped, you will be guided through a series of simple questions (about subscription information).  Depending on your choices you can show the Vibrant Life Wednesday Letter as one of your "active channels" which will automatically download the new Wednesday Letter every month.  In this way you can have the Wednesday Letter delivered to your desktop during the night (or your schedule) for immediate viewing in your browser.  You can turn on or off this channel, at will, and delete the channel from your desktop at any time.  With this feature operating you can click on the Wednesday Letter channel at any time to read the most recent copy of this electronic letter.


You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:&nb